UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study

Leukemia, 2010-05, Vol.24 (5), p.909-913

2010

Volltextzugriff (PDF)

Aberrantly low STAT3 and STAT5 responses are associated with poor outcome and an inflammatory gene expression signature in pediatric acute myeloid leukemia

Clinical & translational oncology, 2021-10, Vol.23 (10), p.2141-2154

2021

Volltextzugriff (PDF)

Merging of the National Cancer Institute-funded cooperative oncology group data with an administrative data source to develop a more effective platform for clinical trial analysis and comparative effectiveness research: a report from the Children's Oncology Group

Pharmacoepidemiology and drug safety, 2012-05, Vol.21 (S2), p.37-43

2012

Volltextzugriff (PDF)

Relationship between pediatric blood and marrow transplant center volume and day+100 mortality: Pediatric Blood and Marrow Transplant Consortium experience

Bone marrow transplantation (Basingstoke), 2013-04, Vol.48 (4), p.514-522

2013

Volltextzugriff (PDF)

Alpha Hemolytic Streptococcal Infection During Intensive Treatment for Acute Myeloid Leukemia: A Report From the Children’s Cancer Group Study CCG-2891

Journal of clinical oncology, 2000-05, Vol.18 (9), p.1845-1855

2000

Volltextzugriff (PDF)

Evaluation for bleeding disorders in suspected child abuse

Pediatrics (Evanston), 2013-04, Vol.131 (4), p.e1314-e1322

2013

Volltextzugriff (PDF)

Treatment of Scedosporiosis with Voriconazole: Clinical Experience with 107 Patients

Antimicrobial Agents and Chemotherapy, 2008-05, Vol.52 (5), p.1743-1750

2008

Volltextzugriff (PDF)

Predictors and short-term outcomes of hyperleukocytosis in children with acute myeloid leukemia: a report from the Children's Oncology Group

Haematologica (Roma), 2012-11, Vol.97 (11), p.1770-1773

2012

Volltextzugriff (PDF)

Ligand-induced STAT3 signaling increases at relapse and is associated with outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group

Haematologica (Roma), 2015-12, Vol.100 (12), p.e496-e500

2015

Volltextzugriff (PDF)

Increased Age at Diagnosis Has a Significantly Negative Effect on Outcome in Children With Down Syndrome and Acute Myeloid Leukemia: A Report From the Children’s Cancer Group Study 2891

Journal of clinical oncology, 2003-09, Vol.21 (18), p.3415-3422

2003

Volltextzugriff (PDF)

Oral care with vancomycin paste for reduction in incidence of alpha-hemolytic streptococcal sepsis

Journal of pediatric hematology/oncology, 1995-05, Vol.17 (2), p.151-155

1995

Volltextzugriff (PDF)

Bilirubinuria: An Early Indicator of Gallbladder Hydrops Associated with Kawasaki Disease

Journal of pediatric gastroenterology and nutrition, 1989-04, Vol.8 (3), p.384-386

1989

Volltextzugriff (PDF)

Hematopoietic stem cell transplantation (HSCT) with a conditioning regimen of busulfan, cyclophosphamide, and etoposide for children with acute myelogenous leukemia (AML): A phase I study of the pediatric blood and marrow transplant consortium

Medical and pediatric oncology, 2000-10, Vol.35 (4), p.403-409

2000

Volltextzugriff (PDF)

CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531

Journal of clinical oncology, 2017-08, Vol.35 (23), p.2674-2682

2017

Volltextzugriff (PDF)

Effectiveness of supportive care measures to reduce infections in pediatric AML: a report from the Children's Oncology Group

Blood, 2013-05, Vol.121 (18), p.3573-3577

2013

Volltextzugriff (PDF)

Busulfan in Infant to Adult Hematopoietic Cell Transplant Recipients: A Population Pharmacokinetic Model for Initial and Bayesian Dose Personalization

Clinical cancer research, 2014-02, Vol.20 (3), p.754-763

2014

Volltextzugriff (PDF)

Genomic Profiling of Pediatric Acute Myeloid Leukemia Reveals a Changing Mutational Landscape from Disease Diagnosis to Relapse

Cancer research (Chicago, Ill.), 2016-04, Vol.76 (8), p.2197-2205

2016

Volltextzugriff (PDF)

Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children’s Oncology Group trial AAML0531

Journal of clinical oncology, 2014-09, Vol.32 (27), p.3021-3032

2014

Volltextzugriff (PDF)

Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children's Oncology Group AAML0431 trial

Blood, 2017-06, Vol.129 (25), p.3304-3313

2017

Volltextzugriff (PDF)

Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971

Blood, 2011-12, Vol.118 (26), p.6752-6759

2011

Volltextzugriff (PDF)

NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report

Blood, 2014-10, Vol.124 (15), p.2400-2407

2014

Volltextzugriff (PDF)

Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group

Clinical cancer research, 2016-04, Vol.22 (8), p.1951-1957

2016

Volltextzugriff (PDF)

CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children's Oncology Group

Blood, 2021-09, Vol.138 (13), p.1137-1147

2021

Volltextzugriff (PDF)

Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group

Blood, 2012-08, Vol.120 (8), p.1581-1588

2012

Volltextzugriff (PDF)

Effect of Dexrazoxane on Left Ventricular Systolic Function and Treatment Outcomes in Patients With Acute Myeloid Leukemia: A Report From the Children's Oncology Group

Journal of clinical oncology, 2020-07, Vol.38 (21), p.2398-2406

2020

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Aktive Filter

ThemaInfant

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(71)

Publikationsform

Artikel
(83)

Sprache

Englisch
(83)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

Humans
(83)
Life Sciences & Biomedicine
(79)
Science & Technology
(79)
Child, Preschool
(76)
Child
(75)
Male
(73)
Female
(69)
Adolescent
(64)
Oncology
(51)
Hematology
(49)
Young Adult
(43)
Prognosis
(35)
Pediatrics
(34)
Infant, Newborn
(33)
Adult
(32)
Leukemia, Myeloid, Acute - Genetics
(32)
Treatment Outcome
(29)
Leukemia, Myeloid, Acute - Drug Therapy
(26)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(24)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study

Aberrantly low STAT3 and STAT5 responses are associated with poor outcome and an inflammatory gene expression signature in pediatric acute myeloid leukemia

Merging of the National Cancer Institute-funded cooperative oncology group data with an administrative data source to develop a more effective platform for clinical trial analysis and comparative effectiveness research: a report from the Children's Oncology Group

Relationship between pediatric blood and marrow transplant center volume and day+100 mortality: Pediatric Blood and Marrow Transplant Consortium experience

Alpha Hemolytic Streptococcal Infection During Intensive Treatment for Acute Myeloid Leukemia: A Report From the Children’s Cancer Group Study CCG-2891

Evaluation for bleeding disorders in suspected child abuse

Treatment of Scedosporiosis with Voriconazole: Clinical Experience with 107 Patients

Predictors and short-term outcomes of hyperleukocytosis in children with acute myeloid leukemia: a report from the Children's Oncology Group

Ligand-induced STAT3 signaling increases at relapse and is associated with outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group

Increased Age at Diagnosis Has a Significantly Negative Effect on Outcome in Children With Down Syndrome and Acute Myeloid Leukemia: A Report From the Children’s Cancer Group Study 2891

Oral care with vancomycin paste for reduction in incidence of alpha-hemolytic streptococcal sepsis

Bilirubinuria: An Early Indicator of Gallbladder Hydrops Associated with Kawasaki Disease

Hematopoietic stem cell transplantation (HSCT) with a conditioning regimen of busulfan, cyclophosphamide, and etoposide for children with acute myelogenous leukemia (AML): A phase I study of the pediatric blood and marrow transplant consortium

CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531

Effectiveness of supportive care measures to reduce infections in pediatric AML: a report from the Children's Oncology Group

Busulfan in Infant to Adult Hematopoietic Cell Transplant Recipients: A Population Pharmacokinetic Model for Initial and Bayesian Dose Personalization

Genomic Profiling of Pediatric Acute Myeloid Leukemia Reveals a Changing Mutational Landscape from Disease Diagnosis to Relapse

Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children’s Oncology Group trial AAML0531

Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children's Oncology Group AAML0431 trial

Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971

NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report

Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group

CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children's Oncology Group

Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group

Effect of Dexrazoxane on Left Ventricular Systolic Function and Treatment Outcomes in Patients With Acute Myeloid Leukemia: A Report From the Children's Oncology Group

Aktive Filter

Suchergebnisse filtern